Insider Shareholders with Direct Ownership of Lineage Cell Therapeutics, Inc. (LCTX)
This section provides a comprehensive overview of the insiders with direct ownership of Lineage Cell Therapeutics, Inc. (LCTX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Lineage Cell Therapeutics, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Broadwood Partners, L.P.
Director |
14,397,001 | 0 | 34,935,485 $29 Million | 11 |
Mar 25, 2022
Added 1.33%
|
|
Alfred D Kingsley
Chairman |
61,800 | 0 | 5,470,245 $4.54 Million | 1 |
Jun 22, 2021
Added 1.12%
|
| 31,720 | 0 | 258,555 $214,600 | 2 |
Mar 24, 2022
Added 2.64%
|
|
|
Brian M Culley
President and CEO |
507,748 | 518,294 | 154,842 $128,518 | 24 |
May 24, 2024
Added 6.07%
|
|
Neal C Bradsher
Director |
24,720 | 0 | 87,628 $72,731 | 1 |
Jun 25, 2021
Added 22.0%
|
| 24,720 | 4,720 | 87,500 $72,625 | 2 |
Jun 29, 2021
Reduced 5.12%
|
|
| 35,000 | 0 | 35,000 $29,050 | 1 |
Mar 28, 2022
Added 50.0%
|
|
| 24,720 | 19,142 | 15,578 $12,929 | 2 |
Jun 29, 2021
Reduced 55.13%
|
|
|
Jill Ann Howe
Chief Financial Officer |
10,500 | 0 | 10,500 $8,715 | 1 |
Aug 16, 2024
Added 50.0%
|
| 10,000 | 0 | 10,000 $8,300 | 1 |
Dec 29, 2023
Added 50.0%
|
|
|
Gary S. Hogge
SVP,Clinical & Medical Affairs |
523,858 | 544,593 | 7,710 $6,399 | 6 |
Feb 11, 2023
Reduced 40.78%
|
|
George A. Samuel Iii
General Counsel/Secretary |
12,152 | 4,968 | 7,184 $5,962 | 4 |
Feb 11, 2024
Reduced 25.74%
|
|
Alexandra Hernandez
Sr Director Finance/Controller |
6,000 | 6,000 | 0 $0 | 2 |
Mar 30, 2021
Reduced 100.0%
|